These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22132117)

  • 21. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
    Heuser I; Yassouridis A; Holsboer F
    J Psychiatr Res; 1994; 28(4):341-56. PubMed ID: 7877114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests.
    Menke A; Arloth J; Best J; Namendorf C; Gerlach T; Czamara D; Lucae S; Dunlop BW; Crowe TM; Garlow SJ; Nemeroff CB; Ritchie JC; Craighead WE; Mayberg HS; Rex-Haffner M; Binder EB; Uhr M
    Psychoneuroendocrinology; 2016 Jul; 69():161-71. PubMed ID: 27107207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
    Schüle C; Baghai T; Zwanzger P; Ella R; Eser D; Padberg F; Möller HJ; Rupprecht R
    Psychopharmacology (Berl); 2003 Mar; 166(3):271-5. PubMed ID: 12552362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H; Ida I; Owashi T; Kimura M; Inoue Y; Nakagawa S; Yabana T; Urushibara T; Kanai R; Aihara M; Yuuki N; Otsubo T; Oshima A; Kudo K; Inoue T; Kitaichi Y; Shirakawa O; Isogawa K; Nagayama H; Kamijima K; Nanko S; Kanba S; Higuchi T; Mikuni M
    Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal responsiveness in the Trier Social Stress Test and the dexamethasone-corticotropin releasing hormone test in healthy individuals.
    Petrowski K; Herhaus B; Conrad R; Bornstein SR
    Psych J; 2021 Apr; 10(2):305-317. PubMed ID: 33511783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortisol and ACTH responses to the Dex/CRH test: influence of temperament.
    Tyrka AR; Wier LM; Price LH; Rikhye K; Ross NS; Anderson GM; Wilkinson CW; Carpenter LL
    Horm Behav; 2008 Apr; 53(4):518-25. PubMed ID: 18294637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.
    Schinke C; Hesse S; Stoppe M; Meyer K; Schmidt E; Orthgiess J; Bechmann L; Bresch A; Rullmann M; Luthardt J; Sabri O; Blüher M; Kratzsch J; Then Bergh F
    Psychoneuroendocrinology; 2017 Apr; 78():39-47. PubMed ID: 28167369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls.
    Carpenter LL; Ross NS; Tyrka AR; Anderson GM; Kelly M; Price LH
    Psychoneuroendocrinology; 2009 Sep; 34(8):1208-13. PubMed ID: 19375869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging.
    Hatzinger M; Reul JM; Landgraf R; Holsboer F; Neumann I
    Neuroendocrinology; 1996 Nov; 64(5):349-56. PubMed ID: 8930935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse.
    Rinne T; de Kloet ER; Wouters L; Goekoop JG; DeRijk RH; van den Brink W
    Biol Psychiatry; 2002 Dec; 52(11):1102-12. PubMed ID: 12460693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action.
    Horstmann S; Dose T; Lucae S; Kloiber S; Menke A; Hennings J; Spieler D; Uhr M; Holsboer F; Ising M
    Psychoneuroendocrinology; 2009 Feb; 34(2):238-248. PubMed ID: 18926641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex-related differential response to dexamethasone in endocrine and immune measures in depressed in-patients and healthy controls.
    Rampp C; Eichelkraut A; Best J; Czamara D; Rex-Haffner M; Uhr M; Binder EB; Menke A
    J Psychiatr Res; 2018 Mar; 98():107-115. PubMed ID: 29331929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
    Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression.
    Veen G; Derijk RH; Giltay EJ; van Vliet IM; van Pelt J; Zitman FG
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):409-15. PubMed ID: 19327969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test.
    Beck-Friis J; Ljunggren JG; Thorén M; von Rosen D; Kjellman BF; Wetterberg L
    Psychoneuroendocrinology; 1985; 10(2):173-86. PubMed ID: 2994141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression.
    Behnken A; Bellingrath S; Symanczik JP; Rieck MJ; Zavorotnyy M; Domschke K; Arolt V; Zwanzger P
    Psychoneuroendocrinology; 2013 Mar; 38(3):447-54. PubMed ID: 22840287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.